Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo

Biochemical and Biophysical Research Communications

Volumn 446, Issue 4, 2014, Pages 983-989

  Lee, Miyoung ^a   Jeong, Sang Young ^a   Ha, Jueun ^a   Kim, Miyeon ^a   Jin, Hye Jin ^a   Kwon, Soon Jae ^a   Chang, Jong Wook ^b   Choi, Soo Jin ^a   Oh, Wonil ^a   Yang, Yoon Sun ^a   Kim, Jae Sung ^c   Jeon, Hong Bae ^a  

^a MEDIPOST Co Ltd   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Allogeneic; Human umbilical cord blood derived mesenchymal stem cell (hUCB MSC); Humanized NSG mouse; Low immunogenicity

Indexed keywords

ALLOGENEIC; HUMAN UMBILICAL CORD BLOOD DERIVED-MESENCHYMAL STEM CELL (HUCB-MSC); HUMANIZED NSG MOUSE; LOW IMMUNOGENICITY;

ANIMALS; ANTIGENS, CD34; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899493349     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.051     Document Type: Article

References (30)

1. S. Knaän-Shanzer Concise review: the immune status of mesenchymal stem cells and its relevance for therapeutic application Stem Cells 32 2014 603 608
2. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
3. P. Comoli, F. Ginevri, R. Maccario, and M.A. Avanzini et al. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation Nephrol. Dial. Transplant. 23 2008 1196 1202
4. G. Chamberlain, J. Fox, B. Ashton, and J. Middleton Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing Stem Cells 25 2007 2739 2749
5. J.Y. Kim, H.B. Jeon, and Y.S. Yang et al. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models World J. Stem Cells 2 2010 34 38
6. S.Y. Jeong, D.H. Kim, and J. Ha et al. Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation Stem Cells 31 2013 2136 2148
7. J.Y. Kim, D.H. Kim, and D.S. Kim et al. Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro FEBS Lett. 584 2010 3601 3608
8. J.Y. Kim, D.H. Kim, and J.H. Kim et al. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-beta plaques Cell Death Differ. 19 2012 680 691
9. M.J. Hoogduijn, M. Roemeling-van Rhijn, and S.S. Korevaar et al. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies Hum. Gene Ther. 22 2011 1587 1591
10. S. Schu, M. Nosov, and L. O'Flynn et al. Immunogenicity of allogeneic mesenchymal stem cells J. Cell Mol. Med. 16 2012 2094 2103
11. L.D. Shultz, F. Ishikawa, and D.L. Greiner Humanized mice in translational biomedical research Nat. Rev. Immunol. 7 2007 118 130
12. L.D. Shultz, B.L. Lyons, and L.M. Burzenski et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells J. Immunol. 174 2005 6477 6489
13. F. Ishikawa, M. Yasukawa, and B. Lyons et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice Blood 106 2005 1565 1573
14. P. Kumar, H.S. Ban, and S.S. Kim et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice Cell 134 2008 577 586
15. J. Unsinger, J.S. McDonough, and L.D. Shultz et al. Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice J. Leukoc. Biol. 86 2009 219 227
16. L.M. Tobin, M.E. Healy, and K. English et al. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease Clin. Exp. Immunol. 172 2013 333 348
17. T. Pearson, D.L. Greiner, L.D. Shultz, Creation of "humanized" mice to study human immunity, Curr. Protoc. Immunol. (Chapter 15) (2008) Unit 15 21.
18. J.S. Hunt, M.G. Petroff, R.H. McIntire, and C. Ober HLA-G and immune tolerance in pregnancy FASEB J. 19 2005 681 693
19. M.M. Lalu, L. McIntyre, and C. Pugliese et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials PLoS ONE 7 2012 e47559
20. T.B. Prigozhina, S. Khitrin, and G. Elkin et al. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation Exp. Hematol. 36 2008 1370 1376
21. A.J. Poncelet, J. Vercruysse, and A. Saliez et al. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo Transplantation 83 2007 783 790
22. Y. Nemoto, T. Kanai, and M. Takahara et al. Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells Gut 62 2013 1142 1152
23. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J. Immunol. 172 2004 2731 2738
24. F. Djouad, C. Bony, and T. Haupl et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells Arthritis Res ther. 7 2005 R1304 R1315
25. O. DelaRosa, E. Lombardo, and A. Beraza et al. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells Tissue Eng. Part A 15 2009 2795 2806
26. S.J. Prasanna, D. Gopalakrishnan, and S.R. Shankar et al. Pro-inflammatory cytokines, IFN gamma and TNF alpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially PLoS ONE 5 2010 e9016
27. M.C. Andre, A. Erbacher, and C. Gille et al. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells J. Immunol. 185 2010 2710 2720
28. Y. Watanabe, T. Takahashi, A. Okajima, and M. Shiokawa et al the analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice) Int. Immunol. 21 2009 843 858
29. S.Y. Joo, Y.S. Chung, and B. Choi et al. Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells Transplantation 94 2012 1095 1102
30. L.D. Shultz, Y. Saito, and Y. Najima et al. Generation of functional human T cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2 gamma (null) humanized mice Proc. Natl. Acad. Sci. USA 107 2010 13022 13027